A guy walks into a bar with a duck and a box under his arm.
"For $10.00 I can make this duck dance."
He put the box on the bar and the duck on the box and the duck starts dancing.
Bartender says, " Here's my 10.00. You know what ? I think I can make a lot of money with that duck. I'll buy him off you for $100.00."
The guy takes the money and leaves and goes home.
The duck dances all night and the bartender makes $300.00. At closing time the bartender calls the guy and says, " Hey...the duck was a smashing success. I've tripled my investment. But...just one question....how do you get him to stop dancing ? It's closing time."
"Oh....you take the duck off the box, open the box, and blow out the candle."
Middle relief is a question-mark for SF.
Royals will win if they walk Panda, Posey, and Pence at every at-bat. Can you do that ??
What day do you think it will happen ??
It needs to be pointed out that Garo used to take a potion of his salary in shares every month and that was a good part of any insider activity with AGEN. That's no longer the case.
But....your point is good...thanks.
I don't think people are thinking AGEN will fail. I think we've just fallen off peoples' radar. We've been down for so long..Shorty has done a masterful job at doing that. You have to hand it to them...they're good at what they do.
But, somewhere down the line, you have to break through all of that and give people a reason to jump on-board something that's moving up. How do you do that ? You do deals. You create excitement.
Building value slowly and methodically is admirable but at some point you have to let the world know you're alive and doing something.
Doing a good job in the lab is like wetting your pants in a dark suit. Makes you feel warm all over but no one notices.
Here's what I wish would happen...20% of the adjuvant royalties have already been sold to Ingalls and Snyder. Sell the remaining 80% to GSK.
Partner Prophage, HerpV, and the CMV vaccines to the highest bidder or best fit.
Turn your full attention onto the checkpoints and get serious involvement with MRK.
Thanks....but when are we going to get some movement with the legacy products ?? What if Prophage and a checkpoint are THE combo for brain cancer ....and no one knew that because a Piii was never run ??
And...what if we did a Piii with HerpV and gave one arm some oral Acyclovir.....and got fantastic results ??
We were promised a partnership....some kind of partnership by the end of the year.
Garo...hire an M&A firm and let them flesh out the deals......
1) Our adjuvant is in the Bill Gates Malaria vaccine plus about 17 other vaccines in development.
2) Our brain cancer vaccine prolongs life by a factor of x2 compared to current Standard of Care. Needs a partner for Piii
3) Our Herpes vaccine reduces viral shedding by 75% in 50% of patients. Needs a partner for Piii.
4) Our deal with 4AB brought a CMV vaccine ready to partner. Needs a partner for Piii.
5) Checkpoints !!!! MRK brought us two of their checkpoints to develop. They came to us !!!
C'mon with the deals !!!!
NewLink beat us to the punch with their deal with Roche today.
C'Mon, Garo......You've got connections with Roche/Genentech. Hyam Levitsky is an ex-Board Member of AGEN. How did you let this money get away ??
NEW YORK (AP) — A newly announced partnership with Genentech on an experimental cancer drug sent shares of NewLink Genetics soaring 15 percent Monday.
NewLink said it will get $150 million upfront from Genentech, a unit of Swiss drugmaker Roche, and could receive more than $1 billion in payments based on milestones, as well as royalties if the drug is approved. The drug, now called NLG919, is in early-stage clinical testing.
The drug is designed to attack a pathway that blocks the body's immune system from working against many types of cancer, according to the Ames, Iowa, company. The drug companies will also work to develop drugs similar to NLG919. Genentech will fund research, development and marketing of the drugs. NewLink will have an option to co-market the drugs in the U.S.
The research team that did the trials on macaques was led by Nancy J. Sullivan of the NIH and included scientists from Okairos, a biotechnology company that is now part of GlaxoSmithKline, and the U.S. Army Medical Research Institute of Infectious Diseases.
So....GSK seems to have the inside edge.....do we think we're a part of this ??
"The United States government plans to fast-track development of a vaccine shown to protect macaque monkeys, but there is no guarantee it will be effective in humans."
We are involved with some kind of Ebola vaccine from 2011 timeframe.
But...we've had no PR or no update on that....ever. No one has ever spoken about it in any CC that I've read.
I've brought it up from time to time here and no one has ever responded to me.
I'm thinking that if there was anything to our deal regarding Ebola...we would have heard something by now.
But...you never know.....it was a government program....black ops material.